Annovis Bio Inc. (ANVS)
ANVS trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.06
-7.83% on the day
Market cap
$45.2M
Nano cap
Revenue · 2025
$0
Prior year not contiguous
Net income · 2025
-$28.9M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ANVS on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001477845 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$28.9M |
| Operating income | -$29.7M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | $19.5M |
| Total assets | $21.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-05-20 |
| Latest annual report | 10-K | 2026-03-13 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report FORM 8-K | 8-K | 2026-08-14 |
| Latest proxy | DEFA14A | 2026-10-07 |
Source: SEC EDGAR submissions feed, 306 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CELU | Celularity Inc. | $1.42 | -3.40% | $46.1M |
| SER | Serina Therapeutics Inc. | $1.82 | -6.19% | $46.2M |
| DWTX | Dogwood Therapeutics Inc. | $1.30 | -5.11% | $44.2M |
| ACET | Adicet Bio Inc. | $5.11 | -7.59% | $47.8M |
| ELTX | Elicio Therapeutics Inc. | $1.77 | -5.85% | $48.0M |
| HOWL | Werewolf Therapeutics Inc. | $0.9911 | +0.95% | $48.2M |
| CLNN | Clene Inc. | $3.39 | -7.88% | $48.2M |
| GRCE | Grace Therapeutics Inc. | $1.99 | -1.49% | $41.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier